DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,339,344 | +6.3% | 53,766 | +7.9% | 0.08% | +7.0% |
Q2 2023 | $12,554,615 | 0.0% | 49,812 | 0.0% | 0.07% | 0.0% |
Q1 2023 | $12,554,615 | -76.3% | 49,812 | -75.0% | 0.07% | -77.1% |
Q4 2022 | $52,902,186 | +31.1% | 199,315 | +27.5% | 0.31% | +22.0% |
Q3 2022 | $40,364,000 | +204.4% | 156,281 | +198.8% | 0.25% | +225.6% |
Q2 2022 | $13,259,000 | -6.1% | 52,306 | +8.6% | 0.08% | +13.0% |
Q1 2022 | $14,127,000 | -11.7% | 48,163 | -1.0% | 0.07% | -9.2% |
Q4 2021 | $16,006,000 | +11.0% | 48,656 | +2.7% | 0.08% | +1.3% |
Q3 2021 | $14,415,000 | +12.2% | 47,355 | -1.1% | 0.08% | +13.6% |
Q2 2021 | $12,846,000 | +19.7% | 47,875 | +0.4% | 0.07% | +13.8% |
Q1 2021 | $10,729,000 | +1.9% | 47,674 | +0.6% | 0.06% | 0.0% |
Q4 2020 | $10,527,000 | +2.0% | 47,397 | -1.1% | 0.06% | -6.5% |
Q3 2020 | $10,321,000 | +18.1% | 47,942 | -3.0% | 0.06% | +17.0% |
Q2 2020 | $8,739,000 | +9.7% | 49,427 | -4.8% | 0.05% | +47.2% |
Q1 2020 | $7,968,000 | 0.0% | 51,930 | 0.0% | 0.04% | 0.0% |
Q4 2019 | $7,968,000 | +14.3% | 51,930 | +7.6% | 0.04% | +12.5% |
Q3 2019 | $6,972,000 | +3.8% | 48,283 | +2.7% | 0.03% | +10.3% |
Q2 2019 | $6,716,000 | +13.5% | 47,000 | +4.8% | 0.03% | +7.4% |
Q1 2019 | $5,918,000 | +22.0% | 44,840 | -4.7% | 0.03% | +12.5% |
Q4 2018 | $4,852,000 | +8.5% | 47,060 | +14.3% | 0.02% | +33.3% |
Q3 2018 | $4,472,000 | +1.7% | 41,166 | -7.7% | 0.02% | -5.3% |
Q2 2018 | $4,399,000 | -9.7% | 44,579 | -15.1% | 0.02% | -5.0% |
Q1 2018 | $4,871,000 | 0.0% | 52,496 | 0.0% | 0.02% | 0.0% |
Q4 2017 | $4,871,000 | +0.0% | 52,496 | -7.5% | 0.02% | -4.8% |
Q3 2017 | $4,869,000 | -72.7% | 56,782 | -72.7% | 0.02% | -75.3% |
Q2 2017 | $17,818,000 | 0.0% | 208,342 | 0.0% | 0.08% | 0.0% |
Q1 2017 | $17,818,000 | +13.3% | 208,342 | +3.1% | 0.08% | -1.2% |
Q4 2016 | $15,726,000 | -3.8% | 202,044 | -3.1% | 0.09% | -6.5% |
Q3 2016 | $16,346,000 | -57.1% | 208,546 | -44.8% | 0.09% | -60.2% |
Q2 2016 | $38,135,000 | -1.9% | 377,582 | -7.9% | 0.23% | -8.3% |
Q1 2016 | $38,881,000 | -9.6% | 409,881 | -11.5% | 0.25% | -14.3% |
Q4 2015 | $43,007,000 | +32.4% | 463,057 | +21.5% | 0.29% | +23.5% |
Q3 2015 | $32,475,000 | +6.4% | 381,135 | +6.8% | 0.24% | +8.2% |
Q2 2015 | $30,530,000 | -2.6% | 356,716 | -3.4% | 0.22% | -3.9% |
Q1 2015 | $31,353,000 | +48.2% | 369,316 | +49.6% | 0.23% | +38.0% |
Q4 2014 | $21,158,000 | -17.5% | 246,873 | -26.8% | 0.17% | -26.2% |
Q3 2014 | $25,631,000 | +1.6% | 337,355 | +5.3% | 0.22% | -0.9% |
Q2 2014 | $25,222,000 | +49.6% | 320,377 | +42.5% | 0.23% | +45.5% |
Q1 2014 | $16,861,000 | +5.6% | 224,831 | +8.7% | 0.16% | -4.3% |
Q4 2013 | $15,966,000 | +12.0% | 206,837 | +0.5% | 0.16% | -3.6% |
Q3 2013 | $14,260,000 | +7.1% | 205,750 | -2.2% | 0.17% | +1.8% |
Q2 2013 | $13,319,000 | +332875.0% | 210,447 | +284287.8% | 0.17% | – |
Q1 2013 | $4,000 | 0.0% | 74 | 0.0% | 0.00% | – |
Q4 2012 | $4,000 | 0.0% | 74 | 0.0% | 0.00% | – |
Q3 2012 | $4,000 | -99.7% | 74 | -99.7% | 0.00% | -100.0% |
Q1 2012 | $1,477,000 | +294.9% | 26,375 | +410.6% | 0.08% | +26.6% |
Q4 2007 | $374,000 | -59.9% | 5,165 | -54.2% | 0.06% | -49.2% |
Q3 2007 | $933,000 | +9.5% | 11,285 | 0.0% | 0.13% | +7.7% |
Q2 2007 | $852,000 | -12.6% | 11,285 | -17.3% | 0.12% | -23.0% |
Q1 2007 | $975,000 | +160.7% | 13,650 | +164.3% | 0.15% | +137.5% |
Q4 2006 | $374,000 | – | 5,165 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |